Search for: "BRISTOL-MYERS SQUIBB COMPANY" Results 181 - 200 of 469
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Oct 2015, 8:05 am by SEClaw Staff
Two Grant Thornton Firms With Violating Auditor Independence RulesGrant Thornton India LLP and Australia-based Grant Thornton Audit Pty Limited have been charged with auditor independence violations that occurred when two Grant Thornton Mauritius partners served on the boards of Mauritius-based subsidiaries of companies that were Grant Thornton audit clients and performed non-audit services prohibited under the SEC’s auditor independence rules.New Jersey Fund Manager Charged With… [read post]
15 Sep 2015, 8:40 am by Law Offices of Jeffrey S. Glassman
One of the four drugs is Eliquis, manufactured by Bristol-Myers Squibb (BMS), and, according to recent article from Forbes, the drugmaker has a lot riding on Eliquis sales. [read post]
3 Sep 2015, 7:34 am by Law Offices of Jeffrey S. Glassman
Eliquis, manufactured by Bristol-Myers Squibb (BMS) and Pfizer, is now claiming its new oral anticoagulant (NOAC) is safer than other NOACs (Xarelto, Pradaxa, and Savaysa), according to a recent news article from Medpage Today. [read post]
19 Jul 2015, 5:09 pm by Sabrina I. Pacifici
Bristol-Myers Squibb, No. 26, is selling an immunotherapy drug that is saving the lives of people with skin and lung cancer…” Nanette Byrnes [read post]
9 Jul 2015, 3:28 pm by Dr. Shezad Malik
Xarelto, has grabbed a 32 percent market share in the highly competitive anticoagulant market, significantly ahead of Boehringer’s Pradaxa and Bristol-Myers Squibb’s Eliquis, the other two new anticoagulants in the market. [read post]
26 Jun 2015, 11:30 am
  Our readers already know that it took the California Supreme Court less than four months to depublish Bristol-Myers Squibb (reported here). [read post]
19 Jun 2015, 6:30 am by Michael B. Stack
Food and Drug Administration (FDA) approved the first AB-rated generics to Bristol-Myers Squibb and Otsuka’s Abilify® (aripiprazole) tablets, an atypical antipsychotic drug commonly used for treating schizophrenia and bipolar disorder. [read post]
10 Jun 2015, 6:28 pm
Our client started working for Bristol-Myers Squibb in 1989 – staying with the company until she became disabled in November 2010. [read post]
12 May 2015, 3:26 pm by James Galvin
., Inc. 902619386 UBS Yield Optimization Notes with Contingent Protection linked to General Electric Company 902619394 UBS Yield Optimization Notes with Contingent Protection linked to Exxon Mobil Corp. 902619493 UBS Yield Optimization Notes with Contingent Protection linked to Texas Instruments Inc 902619519 UBS Yield Optimization Notes with Contingent Protection linked to Amgen Inc. 902619527 UBS Yield Optimization Notes with Contingent Protection linked to Goldcorp Inc. 902619535 UBS… [read post]
25 Apr 2015, 11:03 am by Schachtman
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
13 Apr 2015, 3:00 am by Steve Brachmann
There’s been a lot of positive activity in recent months for Bristol-Myers Squibb of New York City. [read post]
13 Apr 2015, 3:00 am by Steve Brachmann
There’s been a lot of positive activity in recent months for Bristol-Myers Squibb of New York City. [read post]
10 Apr 2015, 2:00 am
We reported to you last August on Bristol-Myers Squibb Co. v. [read post]
24 Mar 2015, 11:54 am by Dr. Shezad Malik
Xarelto, has grabbed a 32 percent market share in the highly competitive anticoagulant market, significantly ahead of Boehringer’s Pradaxa and Bristol-Myers Squibb’s Eliquis, the other two new anticoagulants in the market. [read post]
26 Feb 2015, 5:00 am
  In Henderson, the plaintiff failed to prove negligence but claimed that “‘even if the Drug Company was not negligent . [read post]
13 Feb 2015, 12:00 pm by Greene LLP
At issue in the case were Bristol-Myers Squibb’s anticoagulant Coumadin and AstraZeneca’s ulcer drugs Prilosec and Nexium. [read post]